Literature DB >> 9264390

Diminished TCR signaling in cutaneous T cell lymphoma is associated with decreased activities of Zap70, Syk and membrane-associated Csk.

M C Fargnoli1, R L Edelson, C L Berger, S Chimenti, C Couture, T Mustelin, R Halaban.   

Abstract

Malignant cells of patients with cutaneous T cell lymphoma (CTCL) are of monoclonal origin and of the CD4+/CD45RO+ subset. Since unlike their normal counterparts, triggering of their TCR/CD3 in vitro elicits only a weak mitogenic response, we set out to determine which of the signal transduction molecules initiated by anti-CD3E antibodies are affected in neoplastic cells. The results obtained from analysis of tumor cells from four patients show a general reduction in basal and induced tyrosine phosphorylation of a wide range of signaling proteins. Furthermore, the function of members from distinct families of protein tyrosine kinases was altered in neoplastic cells. The enzymatic activity of the membrane-bound fraction of Csk was suppressed, and its association with other cellular proteins was altered. There was a decline in the amount and activity of Syk, and a slight decrease in the specific activity of Lck kinases. Zap70 tyrosyl phosphorylation was reduced or undetectable and the kinase associated weakly, or not at all, with the TCR zeta chain. We propose that dampened TCR-triggered responses in CTCL are caused by suppression of an array of effector molecules required for coupling cell surface receptors to early and late signaling events.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9264390     DOI: 10.1038/sj.leu.2400745

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

1.  Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.

Authors:  Thorbjørn Krejsgaard; Andreas Willerslev-Olsen; Lise M Lindahl; Charlotte M Bonefeld; Sergei B Koralov; Carsten Geisler; Mariusz A Wasik; Robert Gniadecki; Mogens Kilian; Lars Iversen; Anders Woetmann; Niels Odum
Journal:  Blood       Date:  2014-06-23       Impact factor: 22.113

2.  Characteristics of TCRζ, ZAP-70, and FcɛRIγ gene expression in patients with T- and NK/T-cell lymphoma.

Authors:  Ziwei Liao; Lingling Zhou; Chunyan Wang; Zhifeng He; Xu Wang; Xiaodan Luo; Shaohua Chen; Lijian Yang; Huo Tan; Yangqiu Li
Journal:  DNA Cell Biol       Date:  2014-12-16       Impact factor: 3.311

3.  Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.

Authors:  Thorbjørn Krejsgaard; Claudia S Vetter-Kauczok; Anders Woetmann; Hermann Kneitz; Karsten W Eriksen; Paola Lovato; Qian Zhang; Mariusz A Wasik; Carsten Geisler; Elisabeth Ralfkiaer; Juergen C Becker; Niels Ødum
Journal:  Blood       Date:  2009-04-07       Impact factor: 22.113

4.  Dysregulated synthesis of intracellular type 1 and type 2 cytokines by T cells of patients with cutaneous T-cell lymphoma.

Authors:  B N Lee; M Duvic; C K Tang; C Bueso-Ramos; Z Estrov; J M Reuben
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

5.  Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides.

Authors:  Benjamin F Chong; Adam J Wilson; Heather M Gibson; Mikehl S Hafner; Yu Luo; Carrie J Hedgcock; Henry K Wong
Journal:  Clin Cancer Res       Date:  2008-02-01       Impact factor: 12.531

6.  Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.

Authors:  Jianqiang Wu; Gary S Wood
Journal:  JAMA Dermatol       Date:  2018-10-01       Impact factor: 10.282

7.  CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in Sézary syndrome patients.

Authors:  Maria Wysocka; Andrew V Kossenkov; Bernice M Benoit; Andrea B Troxel; Elisha Singer; Andras Schaffer; Brian Kim; Tzvete Dentchev; Satoshi Nagata; Tomoko Ise; Louise C Showe; Alain H Rook
Journal:  J Invest Dermatol       Date:  2013-06-21       Impact factor: 8.551

8.  c-CBL E3 ubiquitin ligase is overexpressed in cutaneous T-cell lymphoma: its inhibition promotes activation-induced cell death.

Authors:  Jianqiang Wu; Katrin A Salva; Gary S Wood
Journal:  J Invest Dermatol       Date:  2014-08-14       Impact factor: 8.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.